Debbie Rigby rounds up the latest in research news Mineralocorticoid receptor antagonists and atrial fibrillation A meta-analysis of seven trials showed that the efficacy of MRAs, as compared with placebo, in reducing a composite of cardiovascular death or HF hospitalization. The benefit was consistent across patients with and without heart failure. Pooled data from 20
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.